Authors:
Hobisch, A
Ramoner, R
Fuchs, D
Godoy-Tundidor, S
Bartsch, G
Klocker, H
Culig, Z
Citation: A. Hobisch et al., Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype, CLIN CANC R, 7(9), 2001, pp. 2941-2948
Authors:
Verdorfer, I
Hobisch, A
Culig, Z
Hittmair, A
Bartsch, G
Erdel, M
Duba, HC
Utermann, G
Citation: I. Verdorfer et al., Combined study of prostatic carcinoma by classical cytogenetic analysis and comparative genomic hybridization, INT J ONCOL, 19(6), 2001, pp. 1263-1270
Authors:
Radmayr, C
Schlager, A
Studen, M
Bartsch, G
Citation: C. Radmayr et al., Prospective randomized trial using laser acupuncture versus desmopressin in the treatment of nocturnal enuresis, EUR UROL, 40(2), 2001, pp. 201-205
Authors:
Horninger, W
Volgger, H
Rogatsch, H
Gschwendtner, A
Bartsch, G
Citation: W. Horninger et al., Consideration of low PSA cut-off levels to optimize the detection of curable prostate cancer, EUR UROL, 39, 2001, pp. 43-46
Authors:
Holtl, L
Eder, IE
Klocker, H
Hobisch, A
Bartsch, G
Stenzl, A
Citation: L. Holtl et al., Photodynamic diagnosis with 5-aminolevulinic acid in the treatment of secondary urethral tumors: First in vitro and in vivo results, EUR UROL, 39(2), 2001, pp. 178-182
Authors:
Rimler, A
Culig, Z
Levy-Rimler, G
Lupowitz, Z
Klocker, H
Matzkin, H
Bartsch, G
Zisapel, N
Citation: A. Rimler et al., Melatonin elicits nuclear exclusion of the human androgen receptor and attenuates its activity, PROSTATE, 49(2), 2001, pp. 145-154
Authors:
Strohmeyer, D
Frauscher, F
Klauser, A
Recheis, W
Rogatsch, H
Eibl, G
Horninger, W
Steiner, H
Volgger, H
Bartsch, G
Citation: D. Strohmeyer et al., Contrast-enhanced Transrectal Color Doppler Ultrasonography (TRCDUS) for assessment of angiogenesis in prostate cancer, ANTICANC R, 21(4B), 2001, pp. 2907-2913
Authors:
Zelle-Rieser, C
Ramoner, R
Bartsch, G
Thurnher, M
Citation: C. Zelle-rieser et al., A clinically approved oral vaccine against pneumotropic bacteria induces the terminal maturation of CD83(+) immunostimulatory dendritic cells, IMMUNOL LET, 76(1), 2001, pp. 63-67
Authors:
Roehrborn, CG
Bartsch, G
Kirby, R
Andriole, G
Boyle, P
De La Rosette, J
Perrin, P
Ramsey, E
Nordling, J
Freire, GD
Arap, S
Citation: Cg. Roehrborn et al., Guidelines for the diagnosis and treatment of benign prostatic hyperplasia: A comparative, international overview, UROLOGY, 58(5), 2001, pp. 642-650
Authors:
Bartsch, G
Horninger, W
Klocker, H
Reissigl, A
Oberaigner, W
Schonitzer, D
Severi, G
Robertson, C
Boyle, P
Citation: G. Bartsch et al., Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria, UROLOGY, 58(3), 2001, pp. 417-424
Authors:
Potter, SR
Horniger, W
Tinzl, M
Bartsch, G
Partin, AW
Citation: Sr. Potter et al., Age, prostate-specific antigen, and digital rectal examination as determinants of the probability of having prostate cancer, UROLOGY, 57(6), 2001, pp. 1100-1104
Authors:
Zelle-Rieser, C
Barsoum, AL
Sallusto, F
Ramoner, R
Rohrer, JW
Holtl, L
Bartsch, G
Coggin, JH
Thurnher, M
Citation: C. Zelle-rieser et al., Expression and immunogenicity of oncofetal antigen-immature laminin receptor in human renal cell carcinoma, J UROL, 165(5), 2001, pp. 1705-1709
Authors:
Horninger, W
Volgger, H
Rogatsch, H
Strohmeyer, D
Steiner, H
Hobisch, A
Klocker, H
Bartsch, G
Citation: W. Horninger et al., Predictive value of total and percent free prostate specific antigen in high grade prostatic intraepithelial neoplasia lesions: Results of the Tyrol Prostate Specific Antigen Screening Project, J UROL, 165(4), 2001, pp. 1143-1145
Authors:
Stenzl, A
Jarolim, L
Coloby, P
Golia, S
Bartsch, G
Babjuk, M
Kakizoe, T
Robertson, C
Citation: A. Stenzl et al., Urethra-sparing cystectomy and orthotopic urinary diversion in women with malignant pelvic tumors, CANCER, 92(7), 2001, pp. 1864-1871
Authors:
Horninger, W
Bartsch, G
Snow, PB
Brandt, JM
Partin, AW
Citation: W. Horninger et al., The problem of cutoff levels in a screened population - Appropriateness ofinforming screenees about their risk of having prostate carcinoma, CANCER, 91(8), 2001, pp. 1667-1672